CAS 73392-19-5

L-Lysinamide,N-[(4-methylphenyl)sulfonyl]glycyl-L-prolyl-N-(4-nitrophenyl)-

Description:

L-Lysinamide, N-[(4-methylphenyl)sulfonyl]glycyl-L-prolyl-N-(4-nitrophenyl)-, identified by the CAS number 73392-19-5, is a synthetic compound that belongs to the class of amino acid derivatives. This substance features a complex structure that includes multiple functional groups, such as an amide linkage, a sulfonyl group, and nitrophenyl moieties, which contribute to its chemical reactivity and potential biological activity. The presence of the amino acid residues, specifically lysine, glycine, and proline, suggests that it may interact with biological systems, possibly influencing protein synthesis or enzyme activity. Its sulfonyl and nitrophenyl groups may impart unique properties, such as increased solubility or specific binding affinities. While detailed studies on its pharmacological effects may be limited, compounds of this nature are often explored for their potential applications in medicinal chemistry, particularly in drug design and development. As with any chemical substance, safety and handling precautions should be observed due to the potential for toxicity or reactivity.

Formula: C₂₆H₃₄N₆O₇S

Synonyms:

• Tosyl-Gly-L-Pro-L-Lys p-nitroanilide
• Tos-Gly-Pro-Lys-Pna
• 9: PN:WO2004106541 PAGE: 15 claimed sequence
• Tos-GPK-pNA
• L-Lysinamide, N-[(4-methylphenyl)sulfonyl]glycyl-L-prolyl-N-(4-nitrophenyl)-

Tos-Gly-Pro-Lys-pNA

CAS: 73392-19-5

Chromogenic serine protease substrate, e.g. for tryptase. Tos-GPK-pNA has been used for assaying bovine duodenase.

Formula: C₂₆H₃₄N₆O₇S

Purity: 99.7%

Color and Shape: Light Yellow

Molecular weight: 574.66

Ref: 01-4010701

Tos-Gly-Pro-Lys-pNA acetate

CAS: 73392-19-5

Tos-Gly-Pro-Lys-pNA acetate is a peptide that has been shown to have inhibitory effects on serine proteases, such as fibrinogen. Tos-Gly-Pro-Lys-pNA acetate binds to the active site of serine proteases, which inhibits their activity and prevents them from cleaving fibrinogen. The rate of reaction is dependent on the concentration of enzyme inhibitors. For example, at low concentrations, the enzyme inhibitor will bind to only one or two sites on the serine protease, while at high concentrations it may bind to many sites. This molecule has been shown to be a potent inhibitor of human immunodeficiency virus (HIV) protease and is currently being studied for its use as a potential antiviral agent.

Formula: C₂₆H₃₄N₆O₇S

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 574.65 g/mol

Ref: 3D-FT110751